Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

PEMF therapy for heel spur pain

Official title: Evaluation of the Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs: A Prospective, Randomized, Sham-Controlled Trial

Run by Kanuni Sultan Suleyman Training and Research Hospital · NCT07919600 · Data updated 2026-11-12

This trial tests whether pulsed electromagnetic field therapy helps reduce morning heel pain in adults with a plantar calcaneal spur, compared with a sham treatment while both groups do daily stretching.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorKanuni Sultan Suleyman Training and Research Hospital
Academic / other
Locations1 site (Küçükçekmece, Istanbul)
StatusRecruiting
StartedAugust 28, 2026
Main results expectedJanuary 29, 2027
Study endsJanuary 29, 2027
Registry record updatedNovember 5, 2026
Trial IDNCT07919600 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-65 with heel pain for at least 3 months and radiographically confirmed plantar calcaneal spur.

Probably not a fit

Individuals with history of inflammatory rheumatic diseases, recent foot surgery, or conditions listed in exclusion criteria may not benefit from PEMF in this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, sham-controlled trial enrolls 100 adults aged 18-65 with radiographically confirmed plantar calcaneal spurs and at least 3 months of heel pain. Participants are assigned 1:1 to active PEMF therapy or sham PEMF therapy, in addition to a standardized stretching program. Outcomes are measured at baseline, 4, 8, and 12 weeks, focusing on morning first-step pain, foot function, plantar fascia thickness by ultrasound, and pressure pain threshold. The study aims to determine if PEMF provides short- to medium-term pain relief and functional improvement beyond stretching alone.

Why it matters

Potential benefit: If successful, PEMF therapy could reduce morning heel pain and improve foot function for people with plantar calcaneal spurs.

How similar studies have gone: Sham-controlled trials of PEMF in musculoskeletal conditions have shown mixed results; this study adds controlled evidence specifically for plantar calcaneal spurs.

Who can join: the full rules

Show full inclusion / exclusion criteria
\*\*Inclusion Criteria:\*\*

* Adults aged 18-65 years.
* Heel pain persisting for at least 3 months.
* Radiographically confirmed plantar calcaneal spur on lateral foot radiography.

\*\*Exclusion Criteria:\*\*

* Symptomatic Achilles tendinopathy or retrocalcaneal bursitis.
* Partial or complete plantar fascia rupture.
* Calcaneal stress or insufficiency fracture.
* Heel fat pad syndrome or fat pad atrophy.
* Tarsal tunnel syndrome or other peripheral neuropathies.
* Foot pain associated with S1 radiculopathy.
* Inflammatory rheumatic diseases or gout.
* Active infection.
* Malignancy.
* Severe lower extremity deformity or previous calcaneal/foot surgery.
* Corticosteroid or platelet-rich plasma (PRP) injection into the plantar region within the previous 6 months.
* Extracorporeal shock wave therapy (ESWT) within the previous 6 months.
* Requirement for regular nonsteroidal anti-inflammatory drugs (NSAIDs) or analgesic medication.
* Diabetes mellitus.
* Significant peripheral vascular disease.
* Pregnancy or breastfeeding.
* Presence of a cardiac pacemaker or other implanted electronic devices.

Where it's running

  • Kanuni Sultan Suleyman Training and Research Hospital
    Küçükçekmece, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.